Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy

Contact Dermatitis

Volumn 38, Issue 4, 1998, Pages 209-211

  Schnuch, A ^a,b   Westphal, G A ^b   Muller M M ^b   Schulz, T G ^b   Geier, J ^a   Brasch, J ^a   Merk, H F ^a   Kawakubo, Y ^a   Richter, G ^a   Koch, P ^a   Fuchs, Th ^a   Gutgesell, T ^b   Reich, K ^b   Gebhardt, M ^a   Becker, D ^a   Grabbe, J ^a   Szliska, C ^a   Aberer, W ^a   Hallier, E ^b  

^a Information Network of Departments of Dermatology (IVDK)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acetylator genotype; Acetylator phenotype; Allergic contact dermatitis; Aryl amines; Clinical epidemiology; Genetic susceptibilty; Molecular epidemiology

Indexed keywords

ACYLTRANSFERASE; CAFFEINE DERIVATIVE; METHYLXANTHINE; URACIL DERIVATIVE;

ACETYLATION; ACETYLATOR PHENOTYPE; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HEALTH CARE PERSONNEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; METABOLITE; PHENOTYPE; POLYMERASE CHAIN REACTION; SKIN ALLERGY; SKIN SENSITIVITY; URINALYSIS;

ACETYLATION; ARYLAMINE N-ACETYLTRANSFERASE; CAFFEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DERMATITIS, ALLERGIC CONTACT; GENOTYPE; HUMANS; PHENOTYPE; PHOSPHODIESTERASE INHIBITORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SULFAMETHAZINE;

EID: 6844250106     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1998.tb05709.x     Document Type: Article

References (16)

1. Orzechowska-Juzwenko K, Milejski P, Patkowski J, Nittner-Marszalska M, Malolepszy J. Acetylator phenotype in patients with allergic diseases and its clinical significance. Int J Clin Pharmacol Therap Toxicol 1990: 28: 420-425.
2. Kawakubo Y, Nakamori M, Schöpf E, Ohkido M. Acetylator phenotype in patients with p-phenylenediamineallergy. Dermatology 1997: 195: 43-45.
3. Rieder M J, Shear N H, Kanee A, Tang B K, Spielberg S P. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991: 49: 13-17.
4. Schnuch A, Geier J, Uter W, Frosch P J, Lehmacher W, Aberer W, Agathos M, Arnold R, Fuchs Th, Laubstein B, Lischka G, Pietrzyk P M, Rakoski J, Richter G, Rueff F. National rates and regional differences in sensitization to allergens of the standard series. Population adjusted frequencies of sensitization (PAFS) in 40.000 patients from a multicenter study (IVDK). Contact Dermatitis 1997: 37: 200-209.
5. Grant D M, Tang B K, Kalow W. A simple test for acetylator phenotype using caffeine. Br J Clin Pharmac 1984: 17: 459-464.
6. Cascorbi I, Brockmüller J, Mrozikiewicz P M, Bauer S, Loddenkemper R, Roots I. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996: 36: 3961-3966.
7. Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotype activity. Am J Human Genet 1995: 57: 581-592.
8. Moss C, Friedmann P S, Shuster S, Simpson J M. Susceptibility and amplification of sensitivity in contact dermatitis. Clin Exp Immunol 1985: 61: 232-241.
9. Menné T, Holm N V. Genetic susceptibility in human allergic contact sensitization. Semin Dermatol 1986: 5: 301-306.
10. Ishii N, Takahashi K, Kawaguchi H, Nakajima H, Tanaka S, Aoki I. Genetic control of delayed-type hypersensitivity to chromium chloride. Int Arch Allergy Immunol 1993: 100: 333-337.
11. Sato K, Kusaka Y, Zhang Q, Yanagihara M, Ueda K, Morihiro H, Ishii Y. Investigation of the association between mercury sensitization and HLA-DR6. Contact Dermatitis 1996: 34: 295.
12. Krasteva M, Nicolas J-F, Chabeau G, Garrigue J-L, Bour H, Thivolet J, Schmitt D. Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine. Int Arch Allergy Immunol 1993: 102: 200-204.
13. Basketter D A, Lidén C. Further investigation of the prohapten concept: reactions to benzene derivatives in man. Contact Dermatitis 1992: 27: 90-97.
14. Kraeling M E K, Lipicky R J, Bronaugh R L. Metabolism of benzocaine during percutaneous absorption in the hairless guinea pig: acetylbenzocaine formation and activity. Skin Pharmacol 1996: 9: 221-230.
15. Scholes E W, Pendlington R U, Sharma R K, Basketter D A. Skin metabolism of contact allergens. Toxicol In Vitro 1994: 8: 551-553.
16. West W L, Knight E M, Pradhan S, Hinds T S. Interpatient variablity: genetic predisposition and other genetic factors. J Clin Pharmacol 1997: 37: 635-648.